AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Volibose Trio 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Saan Labs

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Volibose Trio 1mg/500mg/0.2mg Tablet

Triginta 1mg/500mg/0.2mg tablets are antidiabetic medications, a combination therapy for adult type 2 diabetes. These tablets help manage blood glucose levels. Administer Triginta with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar responses. Continue taking this medication even with well-controlled blood sugar; unsupervised cessation risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. Remember, this is one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counter them with fast-acting glucose sources (e.g., sugary foods, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Do not use Triginta if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Disclose any history of heart disease to your physician before starting this medication. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is crucial, along with potential blood tests to track blood cell counts and liver function.

Uses of Volibose Trio 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Volibose Trio 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Volibose Trio 1mg/500mg/0.2mg Tablet on an empty stomach.

Common Side effects of Volibose Trio 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Volibose Trio 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Volibose Trio 1mg/500mg/0.2mg Tablet on an empty stomach.

How Volibose Trio 1mg/500mg/0.2mg Tablet works:

The combined antidiabetic medication Volibose Trio Tablet (1mg/500mg/0.2mg) comprises three distinct active ingredients.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Volibose Trio 1mg/500mg/0.2mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Volibose Trio 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Volibose Trio 1mg/500mg/0.2mg tablets is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyUNSAFE

The use of Volibose Trio 1mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Patients with severe kidney disease should especially avoid this medication. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Volibose Trio 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Volibose Trio 1mg/500mg/0.2mg Tablet :

Should you forget a Volibose Trio 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Volibose Trio 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Volibose Trio 1mg/500mg/0.2mg Tablet

Volibose Trio (Glimepiride 1mg/Metformin 500mg/Voglibose 0.2mg) tablets treat type 2 diabetes mellitus in adults. This triple-drug combination—glimepiride, metformin, and voglibose—improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Volibose Trio 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infection.
Volibose Trio 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any ingredient or excipient. Their use is also contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Volibose Trio 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Volibose Trio 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Volibose Trio 1mg/500mg/0...
90
MRP 104
13% off